Further to its intimation dated May 16, 2021 regarding strategic investment in AlgalR NutraPharms , Camlin Fine Sciences has informed that the total cost of the said acquisition shall not exceed INR 6.50 Crores.
The above information is a part of company’s filings submitted to BSE.